Expert Plastic Surgery After Ozempic & GLP-1 Medications

– NEWPORT BEACH, CA –
Plastic Surgery After GLP-1 Medications
Plastic Surgery After GLP-1 Medications
The Aesthetic Society logo
Plastic Surgery After GLP-1 Medications
Plastic Surgery After GLP-1 Medications
Plastic Surgery After GLP-1 Medications

You Lost the Weight. Now Let’s Sculpt the Body You Deserve

GLP-1 medications like Ozempic®, Wegovy®, and Mounjaro® can deliver up to 20%
weight loss within 12 months. However, the remarkable success of these weight loss
medications can leave you with skin laxity such as:

  • Loose, sagging skin around the arms, abdomen, thighs- “Ozempic Body”
  • Deflated or drooping breasts
  • Buttocks sagging and muscle and fat loss- “Ozempic Butt”
  • Hollow cheeks or prematurely aged appearance- “Ozempic Face”
  • A disconnect between your weight loss and how you feel in your body

At The Aesthetic Centers, Dr. Agha has created revolutionary yet comprehensive
techniques in redefining your shape, contour, and confidence. With over 20 years of
experience in Plastic Surgery After Weight Loss, Dr. Agha is the pioneer of High-
Definition Tummy Tuck, High-Definition Body Lift, Spiral Thigh Lift, Internal Dermal-
Bra Breast Lift, J-Thoracoplasty and various buttocks augmentation and reshaping
procedures.

Tummy Tuck Newport Beach, CA

Witness the Prowess on Instagram

What We Can Refine for You

Disclaimer: While a significant number of our patients have undergone weight loss, not all of the individuals shown below experienced weight loss, and those who did may have achieved it through various methods, including GLP-1 medications, bariatric surgery, diet, or exercise.

FACIAL REJUVENATION –

BREAST RESTORATION –

BODY CONTOURING –

BUTTOCK RESHAPING –

Experience You Can Measure: Why Surgical Volume Matters

When it comes to body contouring after GLP-1 weight loss, precision and experience are everything. These are complex, custom procedures that require a deep understanding of skin behavior, tissue quality, and how the body heals — especially after rapid weight loss.

That’s why surgical volume is more than a number — it’s proof of refined technique, surgical stamina, and consistent outcomes. Here’s how Dr. Agha compares to the average plastic surgeon in the U.S.:

ProcedureAverage number of body procedures performed by a typical Plastic Surgeon per year (ASPS)Average Number of body procedures performed by Dr. Agha per yearTotal Number of Procedures performed by Dr. Agha up to 2024
Arm lift2.122+359
Tummy Tuck19.870+1,234
Buttock Reshaping & Augmentation0.850+816
Buttock Lift0.428559
Liposuction34Over 1001,000s
Lower Body Lift + Revisions127+548
Thighplasty1.235+560
Upper Body Lift17+274
DBSM017+285
Breast Lift With Implants16+260
Reverse Tummy Tuck7+151

DR. SIAMAK AGHA MD, PhD, FACS

Innovator, Educator, Scientist & Artist

Board-certified plastic surgeon, Dr. Siamak Agha has spent the last 20 years perfecting the art of body and face contouring surgery. During this time, Dr. Agha has pioneered new techniques in the field of plastic surgery after weight loss. These include the High-Definition Body Lift, Spiral Thigh Lift, Internal Dermal-Bra Breast Lift, J-Thoracoplasty and various buttocks augmentation and reshaping procedures.

Dr. Siamak Agha is:

  • World-renowned Faculty in Body Contouring Surgeries
  • Active Member of the American Society of Plastic Surgeons
  • Diplomat of the American Board of Plastic Surgery
  • Active Member of International Society of Aesthetic Plastic Surgeons
  • Member of the Orange County Society of Plastic Surgeons
  • Fellow of the American College of Surgeons
  • Fellow of the Royal College of Medicine (U.K.)
  • Specialized in Plastic Surgery After Weight Loss and Extreme Makeovers
Plastic Surgery After GLP-1 Medications
Plastic Surgery After GLP-1 Medications
The Aesthetic Society logo
Plastic Surgery After GLP-1 Medications
Plastic Surgery After GLP-1 Medications
Plastic Surgery After GLP-1 Medications

Important Disclaimer:
GLP-1 receptor agonist medications, including semaglutides (such as Ozempic® and Wegovy®) and tirzepatides (such as Mounjaro®), are prescription drugs intended for the management of type 2 diabetes and, in some cases, weight loss under medical supervision. These medications are not suitable for everyone and should only be used as prescribed by a qualified healthcare provider.

Potential side effects of GLP-1 medications may include nausea, vomiting, diarrhea, abdominal pain, and reduced appetite. More serious risks, such as pancreatitis, gallbladder disease, kidney issues, and thyroid tumors, have been reported in some cases. It is essential to discuss your medical history and any pre-existing conditions with your doctor before starting treatment.

This blog is for informational purposes only and does not constitute medical advice. If you are considering GLP-1 medication, consult with a licensed healthcare professional to determine if it is appropriate for you.

Ozempic®, Mounjaro®, and Wegovy® are registered trademarks of their respective manufacturers.